Skip to main content
. 2014 Aug 19;5(18):8750–8764. doi: 10.18632/oncotarget.2373

Table 2. RNAseq analysis on PDX comparing 6 pairs of treated versus untreated samples.

Top Canonical Pathways P-Value
Protein Kinase A Signaling 3.58E-05
GNRH Signaling 2.74E-04
Sphingosine-1-phosphate signaling 5.4E-04
α-Adrenergic signaling 9.39E-04
Cholecystokinin/Gastrin-mediated signaling 1.91E-03
Molecular and Cellular Functions
Lipid Metabolism 1.33E-04 to 3.80E-02
Molecular Transport 1.33E-04 to 3.80E-02
Small Molecule Biochemistry 1.33E-04 to 3.80E-02
Cell Morphology 1.64E-04 to 3.80E-02
Cellular Assembly and Organization 1.64E-04 to 3.75E-02
Top Up-Regulated Molecules Fold-Change Expression
ZNF750 2.441
ACP5 2.294
HIST2H2BE 2.141
CPEB3 2.117
DNM3 2.028
MPC1 1.980
ABCG1 1.938
MGLL 1.924
TLR5 1.884
Top Down-Regulated Molecules Fold-Change Expression
APOC1 -2.488
GPHA2 -2.262
POLR3G -1.862
TES -1.759
PLCE1 -1.738
PUS7 -1.618
ARNT2 -1.607
MECOM -1.570
CKAP4 -1.564
KLF5 -1.554